Related Experiment Video
Updated: Jun 18, 2026
11:17
Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
Rotigotine for restless legs syndrome
1Medical Information Department, Thomson Reuters, Barcelona, Spain. scientific.prousjournals@thomsonreuters.com
Drugs of Today (Barcelona, Spain : 1998)
|December 4, 2009
Summary
Restless Legs Syndrome (RLS) is a neurological condition impacting leg sensations and movement, often disrupting sleep. Rotigotine transdermal patch (Neupro) offers a treatment option by replenishing dopamine levels.
Area of Science:
- Neurology
- Pharmacology
Background:
- Restless Legs Syndrome (RLS) is a neurological disorder characterized by unpleasant leg sensations and movement urges.
- RLS significantly impairs sleep quality and patient quality of life, particularly due to nighttime symptoms.
Purpose of the Study:
- To evaluate the rotigotine transdermal patch system (Neupro; SPM-962) for the treatment of Restless Legs Syndrome.
- To assess the efficacy of rotigotine in restoring proper motor functioning by addressing dopamine level deficiencies.
Main Methods:
- Development of rotigotine transdermal patch system (Neupro; SPM-962).
- Once-daily application of the transdermal patch to replace dopamine levels.
- Clinical evaluation of the patch system for RLS treatment.
Main Results:
- The rotigotine patch system has been developed as a therapeutic option for RLS.
- The system aims to restore motor function by supplementing dopamine levels.
- Rotigotine transdermal patch (Neupro) received authorization for RLS treatment in August 2008.
Conclusions:
- Rotigotine transdermal patch (Neupro) is an authorized treatment for Restless Legs Syndrome.
- The patch system provides a once-daily application for managing RLS symptoms.
- Dopamine replacement via rotigotine patch aims to improve motor function and quality of life for RLS patients.
More Related Videos
Related Concept Videos
01:27Restless Leg Syndrome and Night Terrors
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
01:15REM Sleep Behavior Disorder
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:21Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...